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H ematologic malignancies account for almost 10% of new cancer diagnoses annually in the United States (1) and represent abnormal proliferation of hematopoietic or lymphoid cell lines (2) . Patients with these malignancies are immunocompromised because of the clonal expansion of malignant cells in the bone marrow that disrupts normal immunologic function. Furthermore, treatment for hematologic malignancies is commonly immunosuppressive, whether through chemotherapy or marrow irradiation or after bone marrow transplantation (3) . Additionally, chemotherapy may compromise the normal barrier function provided by the skin-a compromise that is manifest clinically as oral and Implication for Patient Care n MR imaging can be used successfully to depict perianal inflammation, abscesses, and fistulas in patients with hematologic malignancies and perianal symptoms and to distinguish such patients from immunocompetent individuals.
Advances in Knowledge
n Patients with hematologic malignancies and perianal symptoms had considerably greater perianal edema than did immunocompetent patients with cryptoglandular disease (58.7% vs 13.4% of anal canal height inflamed).
n Perianal fistulas were less common in patients with hematologic malignancies with perianal symptoms (21 [ n Patients with hematologic malignancies and perianal symptoms formed perianal and pelvic abscesses in 26.3% of cases (10 of 38), even in the presence of neutropenia.
n Acute surgical treatment was required in only approximately 10% of patients (four of 38) with hematologic malignancies and perianal symptoms.
n MR imaging can help discriminate between the appearance of perianal infection in patients with hematologic malignancies and that in immunocompetent patients in most cases (areas under the receiver operating characteristic curve, 0.91 and 0.97). Abbreviations: AUC = area under the ROC curve CI = confidence interval ROC = receiver operating characteristic STIR = short inversion time inversion recovery
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perianal mucositis, which predisposes to infection (4) . Perianal infection occurs in approximately 5%-10% of patients with acute leukemia (5) (6) (7) (8) and may occasionally be the presenting complaint (9) . The underlying pathophysiology is believed to be no different from that in immunocompetent patients-that is, infection begins in the intersphincteric anal glands (10) . However, the clinical manifestation may be modified by immunocompromise and impaired pus formation due to neutropenia. This results in diffuse perianal swelling, edema, and erythema rather than the more typical fluctuant collection (11) . Although clinically obvious abscesses require prompt drainage to prevent systemic sepsis or even death (6) , clinicians may be reluctant to examine the anus and rectum of immunocompromised patients for fear of provoking bacteremia and deterioration. Indeed, consensus guidelines prohibit digital rectal examination of patients with neutropenia (12) . This causes a diagnostic dilemma: Occult infection requires prompt identification and treatment, particularly with an attenuated host immune response, but detailed physical examination is relatively contraindicated. Magnetic resonance (MR) imaging can help resolve this by demonstrating the presence, extent, and distribution of perianal sepsis, allowing surgical intervention to be appropriately planned (13) .
Here, we test the hypotheses that (a) perianal abscess formation is less common in patients with hematologic malignancies than in immunocompetent individuals and (b) that diffuse perianal edema is more common. We aimed to use MR imaging to document the distribution and morphology of perianal disease in patients with hematologic malignancies and in immunocompetent control patients.
Materials and Methods
Ethical permission and patient consent are not required by our institution for retrospective review of imaging series acquired during normal patient care.
Patient Selection
Using the hospital radiology information system, we identified patients who had undergone anorectal MR imaging between January 2007 and March 2014 (inclusive) after being referred by a hemato-oncologist. Patients were included if they had been given a diagnosis of hematologic malignancy according to their electronic patient record and if they were imaged for the evaluation of perianal symptoms and/or systemic sepsis. Exclusion criteria were a diagnosis of Crohn disease or nonhematologic malignancy or previous anorectal surgery. Thirty-eight patients with hematologic malignancies underwent 50 MR imaging examinations during the study period. Because we expected repeat examinations in the same patient to be more similar than those from different individuals (ie, clustered), only the earliest MR imaging study was used for initial analysis. However, we subsequently
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For each patient, we chose a control patient, defined as the next sex-and age-matched patient (to within 5 years) who underwent imaging after the study patient. Control patients had been imaged for perianal symptoms and/or systemic sepsis but had no preceding diagnosis of malignancy, immunocompromise, or Crohn disease according to their electronic patient record. Control patients were followed up for a median of 4.3 years (interquartile range: 2.1-5.8 years; range, 1.6-7.5 years) to confirm that these diseases did not develop subsequently.
Clinical Data Recorded
For patients with hematologic malignancies we recorded the following: (a) age and sex; (b) the hematologic diagnosis; (c) current or recent (,3 months) use of chemotherapy; (d) any previous bone marrow transplantation and, if relevant, its type; (e) the lowest neutrophil count at the time of imaging (within 2 weeks of the examination date); (f) perianal symptoms; (g) requirement for immediate (1 week) surgical drainage; and (h) any subsequent need for re-drainage, examination under anesthesia, or specific treatment for perianal fistula. For control patients, we recorded a and f-h from the above list.
Imaging Protocol and Viewing Conditions
All patients were imaged with one of five MR imaging units: three units with a 1.5-T field strength (Avanto or Symphony; Siemens, Erlangen, Germany) and two with a 3.0-T field strength (Ingenia or Achieva, Philips, Best, the Netherlands). Imaging protocols comprised sagittal and axial oblique T2-weighted turbo spin-echo sequences, as well as axial oblique and coronal oblique short inversion time inversion recovery (STIR) imaging, angled to the central axis of the anal canal (Table 1) .
Images were viewed independently in a random order with a picture archiving and communication system (Impax 6.4.0.4551; Agfa Healthcare, Mortsel, Belgium) by two abdominal radiologists (A.A.P. [radiologist 1] and G.B. [radiologist 2], with 7 and 6 years of experience in abdominopelvic MR imaging, respectively). Randomization was performed separately for each radiologist by using statistical software (14) . Although the radiologists were aware that they would be interpreting findings in patients with and patients without hematologic malignancies and that there was a clinical suspicion of perianal sepsis, they were blinded to clinical information and results of prior imaging examinations. They were asked to record the presence of the following: (a) discrete fluid collections or abscesses and their number, size, and location; (b) any internal enteric opening in the anal canal; (c) fistulous or sinus tracts and their type (according to classification system of Parks et al [15] ); and (d) any extensions from this primary tract, including their location. An abscess was defined as a localized, rounded collection of predominantly fluid signal intensity that exhibited a mass effect on adjacent structures, and a fistula was defined as an elongated tubular structure with an internal enteric and external opening. The anal canal was defined as that part of the gastrointestinal tract running between the anorectal junction at the level of the puborectalis sling and the external anal margin. Each radiologist made the assessment separately, and disagreements were subsequently resolved in consensus. The radiologists also estimated the proportion of the anal canal and the perianal region that exhibited MR imaging features of inflammation, defined as high signal intensity distinct from that of normal blood vessels on STIR images (16) . This assessment was made by using (a) the axial section judged to be most abnormal, with extent described as the number of hours of an imaginary clock face centered on
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Plumb et al the anal canal, and (b) the coronal section judged to be most abnormal, with extent described as the percentage of the length of the anal canal that appeared inflamed. Finally, the radiologists were asked to classify the patient as having a hematologic malignancy or not by using a 101-point scale. They were informed that existing clinical literature suggested that diffuse perianal inflammation was common in immunocompromised patients (11), but they were not required to use specific MR imaging criteria-instead, they were asked to give their overall clinical opinion. A score of 100 was assigned when the radiologists were certain of the diagnosis of hematologic malignancy; scores of 50 or greater were used to indicate preference for that diagnosis. A score of 0 indicated certainty that the patient was an immunocompetent control patient; scores of less than 50 were used when this was believed to be more likely.
Statistical Analysis
Data were collated by using Excel for Macintosh (Microsoft, Redmond, Wash) and were analyzed by using R, version 2.15.1 (R Foundation for Statistical Computing, Vienna, Austria). Between-group comparisons were performed by using the Mann-WhitneyWilcoxon test. To determine which MR imaging features were more commonly seen in immunocompetent control patients and which predominated in patients with hematologic malignancies, we compared the proportion of patients in each group using the x 2 test (or the Fisher exact test where expected cell counts were  5), considering P , .05 to indicate a significant difference. We used the consensus interpretation of the two radiologists to define the true presence or absence of a particular MR imaging feature. Agreement between radiologists was assessed by means of percentage agreement for binary variables and by means of Bland-Altman limits of agreement for quantitative variables (17) . To determine the ability of MR imaging to help distinguish patients with hematologic malignancies from control patients, we constructed receiver operating characteristic (ROC) curves for each reader using their individual confidence scores (18) . Empiric curve thresholds were taken above and below each confidence score, and smoothed curves used the binormal assumption. Areas under the ROC curve (AUCs) were calculated by using the trapezoidal method; 95% confidence intervals (CIs) for empiric AUCs were constructed according to the method of DeLong et al (19) , and smoothed AUCs were calculated with the percentile method from 2000 bootstrap replicates.
Results

Clinical Characteristics
Patient demographics and clinical features are shown in Table 2 . Men outnumbered women at a rate of approximately two to one. The mean age was 38.9 years in the study group and 41.5 years in the control group. Neutrophil counts were available for 37 of 38 patients with hematologic malignancies: 28 (75.7%) had neutrophil counts of less than 1.0 3 10 9 /L, indicating moderate neutropenia, and 24 (64.9%) were severely neutropenic (neutrophil count, ,0.5 3 10 9 /L) (20) . Only one patient had a normal neutrophil count (.2.5 3 10 9 /L). Seven (18.4%) of the 38 patients had previously undergone bone marrow transplantation (five allografts and two autografts). Twenty-six (68.4%) of the patients were undergoing chemotherapy at the time of the MR imaging examination, and 33 (86.8%) had undergone chemotherapy within 3 months.
The most common symptom provoking MR imaging was pain, in both the study group Note.-Unless otherwise specified, data are numbers of patients, with percentages in parentheses.
* Data are means 6 standard deviations. Fig 1) .
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Fistulas were less common in patients with hematologic malignancies than in control patients, occurring in 15 (39.5%) of 38 such patients versus 35 (92.1%) of 38 control patients (P , .001). An internal opening was visible for 21 (55.3%) patients with hematologic malignancies and 35 (92.1%) control patients (P , .001). Considering
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Plumb et al The amount of abnormal perianal MR imaging signal intensity on the STIR images was considerably greater for patients with hematologic malignancies than for control patients (Fig 2; Figs  E1, E2 [online] ). The mean number of hours of the clock face showing high signal intensity on STIR images was 7.2 for patients with hematologic malignancies (approximately a 220° arc angle), versus 1.9 for control patients (approximately a 60° arc angle, P , .001). Similarly, a longer segment of the anal canal was inflamed in patients with hematologic malignancies (mean, 58.7% length inflamed) than in control patients (mean, 13.4% inflamed; P , .001). There was good agreement between the two radiologists when estimating the amount of abnormal high signal intensity on STIR images for both the clock face estimate (mean difference, 0.039 hours of a clock [1.2° arc angle]; Bland-Altman limits of agreement, 3.3 hours of a clock [98.1°] ; Fig 3a) and the percentage length of anal canal involvement (mean difference, 20.59%; Bland-Altman limits of agreement, 27.3%; Fig 3b) .
Radiologist 1 classified 37 (97.4%) of 38 control patients correctly (ie, assigned a confidence score of , 50), whereas radiologist 2 classified all control patients correctly. The single control patient believed to have a hematologic malignancy by radiologist 1 had a 1.8-cm intersphincteric collection and diffuse anal edema. Patients with hematologic malignancies were categorized correctly in 27 (71.1%) of 38 cases by radiologist 1 and in 25 (65.8%) of 38 cases by radiologist 2. The overall ability of MR imaging to help discriminate patients with hematologic malignancies from control patients was good: AUCs were 0.97 (95% CI: 0.93, 1.00) for the empiric curve and 0.97 (95% CI: 0.90, 0.98) for the smoothed curve for radiologist 1 and 0.90 (95% CI: 0.83, 0.98) for the empiric curve and 0.91 (95% CI: 0.81, 0.97) for the smoothed curve for radiologist 2 (Fig 4) . The sensitivity, specificity, positive predictive value, and negative predictive value for hematologic malignancies, respectively, were 71.1%, 97.4%, 96.4%, and 77.1% for radiologist 1 and 65.8%, 100%, 100%, and 74.5% for radiologist 2. A total of 16 patients with hematologic malignancies were incorrectly categorized as immunocompetent control patients by at least one radiologist. Incorrectly categorized patients were more likely to have a fistula (incorrect: 10 [62.5%] of 16 had a fistula; correct: five [22.7%] of 22 had a fistula; P = .032) and had significantly less edema than correctly categorized patients (mean height inflamed for incorrectly categorized patients, 35.8% of anal canal; mean height inflamed for correctly categorized patients, 81.6%; P , .001).
Subsequent Treatment
Overall, requirement for acute incision and drainage of an abscess did not differ significantly between the two groups (patients with hematologic malignancies: four [10.5%] of 38; control patients: eight [21.1%] of 38; P = .35). However, subsequent performance of examination under anesthesia was significantly less frequent for patients with hematologic malignancies (six [15.8%] of 38) than control patients (34 [89.5%] of 38, P , .001). Only a single patient (2.6%) with a hematologic malignancy required a seton (ie, insertion of a suture along the fistula tract to encourage drainage of pus), whereas 18 control patients (47.4%) did (P , .001). Only two (5.3%) of
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Plumb et al 38 patients with hematologic malignancies had a fistula tract laid open, versus 10 (26.3%) of 38 control patients (P = .025). Additionally, three control patients underwent placement of a fistula plug, and two required an advancement flap (subsequently repeated for recurrence in one case). No patient with a hematologic malignancy died within 4 weeks of their MR imaging examination-that is, the lack of surgical treatment was not due simply to patient death.
Discussion
More than 135 000 patients are given a diagnosis of a hematologic malignancy each year in the United States (21) . Although intensive chemotherapy regimens (often supplemented by bone marrow transplantation) are frequently curative, the resulting immunocompromise may be profound, and serious infections commonly occur. Perianal sepsis occurs in 5%-10% of patients with hematologic malignancies and causes substantial morbidity and, occasionally, death (8) . MR imaging is well established as a valuable technique for assessing perianal infection in patients with cryptoglandular infection and Crohn disease, and surpasses surgical examination under anesthesia because it reveals sites of infection that are clinically occult (13, 16) .
Because of this, we anticipated that the utility of MR imaging would be similarly high in patients with hematologic malignancies. We found that, contrary to our expectation, perianal abscesses were relatively common in patients with hematologic malignancies, including those with neutropenia. Although the ability to form pus is impaired by neutropenia (22) , our data suggest that this is not absolute-we found no significant difference in rates of abscess formation between patients with hematologic malignancies and control patients, and no effect of the degree of neutropenia on the frequency of abscess formation. The size and location of abscesses was also no different between the two groups, supporting the hypothesis that the underlying pathophysiology (cryptoglandular sepsis) is the same in the two groups. Importantly, the MR imaging finding of an abscess does not exclude hematologic malignancy as an underlying etiology.
Reports describing findings of clinical examination have suggested that diffuse edema and induration are common manifestations of perianal disease in hematologic malignancies (11) . Supporting this, using imaging, we found a significantly greater degree of abnormal perianal high signal intensity on STIR images at MR imaging in patients with hematologic malignancies. On average, more than half of the anal canal showed abnormal high signal intensity on STIR images (approximately 60% of both height and radial extent), in comparison to approximately 10%-15% for control patients. The reason for this difference is unclear, but the two main possibilities are either alterations in the host immune response or, alternatively, different micro-organisms opportunistically infecting the immunocompromised host and causing a different clinical phenotype. The former seems more likely, as results in microbiologic series (5, 6, 8, 23) suggest that the pathogens isolated from patients with hematologic malignancies are gut commensals such as Enterobacteriaceae-no different from those in immunocompetent patients. Irrespective of the precise reason, MR imaging appearances clearly differ in patients with hematologic malignancies from those in control patients, and these imaging features do not mandate surgical intervention. This corroborates historical surgical series (23) , in which 55%-88% of cases of perianal infection in patients with hematologic malignancies were controlled by antibiotics alone. In our study, a subset of patients with hematologic malignancies were erroneously believed to be immunocompetent control patients at MR imaging. Such patients had a simple, noninflamed fistula tract, causing the appearances to be similar to those in immunocompetent individuals.
We found that defined fistula tracts were less common in patients with hematologic malignancies (21 of [55.3%] of 38 patients) than in control patients (35 [92.1%] of 38 patients). Accordingly, the rate of performance of examination under anesthesia, seton placement, or other fistula treatment was lower in patients with hematologic malignancies. We propose that recovery from the nadir of neutropenia (eg, after cessation of chemotherapy) allows perianal healing without the need for subsequent treatment, explaining the lower rates of fistula. Conversely, control patients developing perianal sepsis have already developed chronic infection that is beyond the immune system's ability to control and cannot escalate the host response any further. An alternative possibility is that patients with hematologic malignancies were imaged with less severe disease than control patients, meaning that prompt treatment prevented fistulation. This seems unlikely, because we found no difference in the rate of abscess formation, and the inflammatory reaction (as judged by the extent of signal intensity change on STIR images) was greater, implying a more severe initial disease process.
Our study had limitations. First, our cohort was retrospective, although sizeable for a relatively uncommon group. We treated all patients with hematologic malignancies as a single group, whereas in reality, there may be differences in immune function between patients with different subtypes of hematologic malignancies undergoing various treatments. The study was conducted in a Western hemisphere tertiary oncology center: Results may not generalize more widely. All MR imaging studies were interpreted by one of two experienced radiologists, which may also limit generalizability to more general radiologists. We did not administer intravenous contrast medium, which may have reduced our ability to detect abscesses; however, because the MR imaging protocol was the same for both patient groups, this should not affect our overall conclusions. Nonetheless, it is possible that the absolute prevalence of abscesses in both immunocompetent patients and patients with hematologic malignancies was higher than what we report here.
In summary, patients with hematologic malignancies undergoing MR imaging for perianal symptoms have considerably greater local inflammatory signal change than immunocompetent patients with perianal sepsis. Fistula tracts are significantly less common in patients with hematologic malignancies, although rates of abscess formation are not significantly different. Perianal disease in patients with hematologic malignancies rarely required surgical treatment, either at the time of imaging or thereafter. Radiologists should recognize the potential for hematologic malignancies and associated neutropenia to alter the typical MR imaging features of perianal infection.
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